Post-approval studies (Phase 4)Study completedNCT02824224
What this trial is testing
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
Who this might be right for
MenorrhagiaMetrorrhagiaMedicated Intrauterine Devices
Oregon Health and Science University 42